TNL Mediagene
-
Nasdaq Panel Grants TNL Mediagene Continued Listing, Contingent on Meeting $1 Bid Price by January 7, 2026
TNL Mediagene has secured continued listing on The Nasdaq Capital Market, contingent on meeting bid price requirements by January 7, 2026, following a successful appeal. This Asia-focused digital media conglomerate, formed from a merger of The News Lens and Mediagene Inc., offers diverse content and AI-driven advertising services. The company is implementing a reverse stock split to comply with Nasdaq’s $1 bid price rule.